Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records

Abstract The nationwide clinical features of Japanese patients with primary nephrotic syndrome (NS), including minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), or membranous nephropathy (MN), have not yet been reported. We collected the clinical personal records of patients w...

Full description

Bibliographic Details
Main Authors: Naoki Nakagawa, Tomonori Kimura, Ryuichi Sakate, Takehiko Wada, Kengo Furuichi, Hirokazu Okada, Yoshitaka Isaka, Ichiei Narita
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-41909-5
_version_ 1827723254165405696
author Naoki Nakagawa
Tomonori Kimura
Ryuichi Sakate
Takehiko Wada
Kengo Furuichi
Hirokazu Okada
Yoshitaka Isaka
Ichiei Narita
author_facet Naoki Nakagawa
Tomonori Kimura
Ryuichi Sakate
Takehiko Wada
Kengo Furuichi
Hirokazu Okada
Yoshitaka Isaka
Ichiei Narita
author_sort Naoki Nakagawa
collection DOAJ
description Abstract The nationwide clinical features of Japanese patients with primary nephrotic syndrome (NS), including minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), or membranous nephropathy (MN), have not yet been reported. We collected the clinical personal records of patients with primary NS between 2015 and 2018 from the national registry organized by the Japanese Ministry of Health, Labour, and Welfare. Overall, the demographics, chronic kidney disease classification based on glomerular filtration rate and albuminuria, and treatment of 6036 patients were collected: 3394 (56.2%) with MCD, 677 (11.2%) with FSGS, 1455 (24.1%) with MN, and 510 (8.5%) with others. MN patients were older than MCD and FSGS patients (67 vs. 42 and 47 years, respectively). Steroid-dependent NS or frequently relapsing NS was found in 70.2%, 40.5%, and 24.6%, whereas steroid-resistant NS was found in 6.4%, 36.0%, and 37.9% of patients in the MCD, FSGS, and MN, respectively. The present oral prednisolone use (mean dose, mg/day) was 87.2% (21.2), 80.9% (20.0), and 77.5% (18.8) of patients in the MCD, FSGS, and MN, respectively. The national registry of clinical personal records of primary NS could provide an informative insight into the characteristics, clinical features, and treatment approaches for patients with primary NS in Japan.
first_indexed 2024-03-10T21:57:42Z
format Article
id doaj.art-abb8f7ba4c4b4d2fb79f74ffa14f7cb7
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-10T21:57:42Z
publishDate 2023-09-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-abb8f7ba4c4b4d2fb79f74ffa14f7cb72023-11-19T13:04:26ZengNature PortfolioScientific Reports2045-23222023-09-0113111010.1038/s41598-023-41909-5Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal recordsNaoki Nakagawa0Tomonori Kimura1Ryuichi Sakate2Takehiko Wada3Kengo Furuichi4Hirokazu Okada5Yoshitaka Isaka6Ichiei Narita7Division of Cardiology, Nephrology, Pulmonology and Neurology, Department of Internal Medicine, Asahikawa Medical UniversityReverse Translational Research Project, Center for Rare Disease Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)Reverse Translational Research Project, Center for Rare Disease Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)Division of Nephrology, Endocrinology and Metabolism, Tokai University School of MedicineDepartment of Nephrology, Kanazawa Medical University School of MedicineDepartment of Nephrology, Faculty of Medicine, Saitama Medical UniversityDepartment of Nephrology, Osaka University Graduate School of MedicineDivision of Clinical Nephrology and Rheumatology, Kidney Research Center, Niigata University Graduate School of Medical and Dental SciencesAbstract The nationwide clinical features of Japanese patients with primary nephrotic syndrome (NS), including minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), or membranous nephropathy (MN), have not yet been reported. We collected the clinical personal records of patients with primary NS between 2015 and 2018 from the national registry organized by the Japanese Ministry of Health, Labour, and Welfare. Overall, the demographics, chronic kidney disease classification based on glomerular filtration rate and albuminuria, and treatment of 6036 patients were collected: 3394 (56.2%) with MCD, 677 (11.2%) with FSGS, 1455 (24.1%) with MN, and 510 (8.5%) with others. MN patients were older than MCD and FSGS patients (67 vs. 42 and 47 years, respectively). Steroid-dependent NS or frequently relapsing NS was found in 70.2%, 40.5%, and 24.6%, whereas steroid-resistant NS was found in 6.4%, 36.0%, and 37.9% of patients in the MCD, FSGS, and MN, respectively. The present oral prednisolone use (mean dose, mg/day) was 87.2% (21.2), 80.9% (20.0), and 77.5% (18.8) of patients in the MCD, FSGS, and MN, respectively. The national registry of clinical personal records of primary NS could provide an informative insight into the characteristics, clinical features, and treatment approaches for patients with primary NS in Japan.https://doi.org/10.1038/s41598-023-41909-5
spellingShingle Naoki Nakagawa
Tomonori Kimura
Ryuichi Sakate
Takehiko Wada
Kengo Furuichi
Hirokazu Okada
Yoshitaka Isaka
Ichiei Narita
Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records
Scientific Reports
title Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records
title_full Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records
title_fullStr Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records
title_full_unstemmed Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records
title_short Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records
title_sort demographics and treatment of patients with primary nephrotic syndrome in japan using a national registry of clinical personal records
url https://doi.org/10.1038/s41598-023-41909-5
work_keys_str_mv AT naokinakagawa demographicsandtreatmentofpatientswithprimarynephroticsyndromeinjapanusinganationalregistryofclinicalpersonalrecords
AT tomonorikimura demographicsandtreatmentofpatientswithprimarynephroticsyndromeinjapanusinganationalregistryofclinicalpersonalrecords
AT ryuichisakate demographicsandtreatmentofpatientswithprimarynephroticsyndromeinjapanusinganationalregistryofclinicalpersonalrecords
AT takehikowada demographicsandtreatmentofpatientswithprimarynephroticsyndromeinjapanusinganationalregistryofclinicalpersonalrecords
AT kengofuruichi demographicsandtreatmentofpatientswithprimarynephroticsyndromeinjapanusinganationalregistryofclinicalpersonalrecords
AT hirokazuokada demographicsandtreatmentofpatientswithprimarynephroticsyndromeinjapanusinganationalregistryofclinicalpersonalrecords
AT yoshitakaisaka demographicsandtreatmentofpatientswithprimarynephroticsyndromeinjapanusinganationalregistryofclinicalpersonalrecords
AT ichieinarita demographicsandtreatmentofpatientswithprimarynephroticsyndromeinjapanusinganationalregistryofclinicalpersonalrecords